Complement lysis of U937, a nucleated mammalian cell line in the absence of C9: effect of C9 on C5b-8 mediated cell lysis.
Previous studies have demonstrated that in general, nucleated cells are more resistant to killing by serum complement than are erythrocytes. During studies aimed at defining the mechanisms of nucleated cell resistance, we found that the human histiocytic cell line U937 was easily lysed by homologous serum. U937 cells were also killed by serum depleted of C9, but not by serum depleted of C8, implying that the C5b-8 complex was sufficient to cause lysis of these cells. Enumeration of complexes on the cell surface demonstrated that approximately 40-fold more complexes were required to lyse U937 cells in the absence of C9 than in the presence of an excess of C9. Examination of the effects of small amounts of C9 on lysis of U937 cells by the C5b-8 complex demonstrated that at very low doses, C9 inhibited C5b-8 mediated lysis. The use of radiolabeled anti-C8 antibody showed that C5b-8 complexes were eliminated from the surface of U937 cells at 37 degrees C, and C9 at the dose causing inhibition of lysis accelerated the elimination of complexes. These results suggest that the increased lytic potential resulting from binding of small amounts of C9 to C5b-8 complexes is outweighed by enhanced elimination of complexes resulting in decreased cell death.
D002460:Cell Line; D003186:Complement C9 / Q000172:deficiency*; D015938:Complement Membrane Attack Complex; D003165:Complement System Proteins / Q000172:deficiency / Q000502:physiology*; D004306:Dose-Response Relationship, Immunologic; D006461:Hemolysis; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000276:immunology*
D003186:Complement C9; D015938:Complement Membrane Attack Complex; C042295:complement C5b-8 complex; D003165:Complement System Proteins